Torray Investment Partners’s Axsome Therapeutics AXSM Stock Holding History

Torray Investment Partners’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.5M	Sell	14,774 -20	-0.1%	-$3.46K	0.37%	49
2025 Q4	$2.7M	Sell	14,794 -2,625	-15%	-$366K	0.39%	54
2025 Q3	$2.12M	Buy	17,419 +354	+2%	+$39.9K	0.29%	59
2025 Q2	$1.78M	Sell	17,065 -51	-0.3%	-$5.4K	0.26%	63
2025 Q1	$2M	Sell	17,116 -58	-0.3%	-$6.61K	0.3%	66
2024 Q4	$1.45M	Buy	17,174 +5,351	+45%	+$492K	0.21%	79
2024 Q3	$1.06M	Buy	11,823 +76	+0.6%	+$6.63K	0.15%	88
2024 Q2	$946K	Buy	11,747 +1,209	+11%	+$89.5K	0.14%	87
2024 Q1	$841K	Buy	+10,538	New	+$885K	0.13%	86

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Torray Investment Partners's AXSM Position: Q1 2026 in Review

Torray Investment Partners reduced its Axsome Therapeutics (AXSM) stake by 0.14% in Q1 2026, selling an estimated $3.46K and leaving 14,774 shares worth $2.5M. The position accounts for 0.37% of the portfolio, ranked #49.

Torray Investment Partners first reported a position in AXSM in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.7M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

Torray Investment Partners held 14,774 shares of Axsome Therapeutics worth $2.5M as of Q1 2026.
Torray Investment Partners sold 20 Axsome Therapeutics shares in Q1 2026, an estimated $3.46K.
Axsome Therapeutics made up 0.37% of Torray Investment Partners's portfolio in Q1 2026, its #49 holding.
Torray Investment Partners first reported a position in Axsome Therapeutics in Q1 2024 and has held it in 9 quarters since.
Torray Investment Partners's Axsome Therapeutics position peaked at $2.7M in Q4 2025.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Torray Investment Partners's 13F filing for Q1 2026, filed 1 May 2026.